Oncotech Nordic
Tackling the Global Cancer Crisis with Affordable Early Detection
Cancer is one of the world’s most urgent health challenges—responsible for nearly 10 million deaths in 2020, or one in six globally. And the crisis is growing: global cancer diagnoses are projected to reach 35 million by 2050, a 77% increase from 2022, according to the World Health Organization.
Early detection saves lives, but access to effective screening remains uneven, costly, and often unavailable in high-risk regions. Our retinal scan technology offers a breakthrough: affordable, non-invasive pre-screening that can identify early indicators of the world’s most common cancers—including lung, breast, cervical, uterine, prostate, and colon cancers—using just a single eye image.
By scaling this solution, we can empower healthcare systems globally to detect cancer earlier, improve survival rates, and dramatically reduce the cost burden of late-stage treatment.
Portable Pre-Screening
Early detection aims to efficiently identify cancer.
Ophtascan screening technology is the first clinically tested and validated on-demand and real-time cancer screening system. Lightweight and smartphone-enabled, Ophtascan™ is ready for deployment anywhere—from hospitals in New York to clinics in Nairobi. Bring equitable screening to all communities. With minimal equipment and no lab infrastructure, Ophtascan™ helps identify at-risk individuals in real time, enabling targeted intervention, better data collection, and healthier outcomes.
One Image - Instant Insight
A Single Image provides a World of Health Data. This scalable and affordable pre-screening is made possible by
Oncotech Nordic's Ophtascan™AI-powered screening tool using smartphone-captured iris images to non-invasively detect early-stage cancers (lung, cervical, breast, uterine, prostate) and even type 2 diabetes.
Fast, Affordable & Non Invasive
From Iris to Insight — Health in Seconds
Oncotech Nordic’s AI-powered Ophtascan™ reads subtle patterns in the iris to detect early signs of cancer, diabetes, and other conditions — all in under 30 seconds. No blood. No biopsy. Just real-time insight, anywhere in the world. Empower your clinicians with earlier insights into oncological and metabolic conditions — improving triage, personalizing care, and optimizing resource allocation.
Streamline Early Detection
Your Iris Holds the Key to Early Detection
Your eyes are more than windows to the soul — they’re gateways to your health. Empower your clinicians with earlier insights into oncological and metabolic conditions — improving triage, personalizing care, and optimizing resource allocation.
Partnerships in Early Detection
Join Us in Advancing Early Cancer Detection
Oncotech Nordic is scaling breakthrough retinal scan technology that enables affordable, non-invasive pre-screening for the world’s most common cancers. We’re seeking strategic partners to help deploy this life-saving innovation across healthcare systems and markets worldwide. If you're ready to invest in accessible diagnostics with global impact—let’s talk.
See For Yourself
Saves Lives, Time, Money and Resources
This technology is portable, intuitive, and designed for global scalability. Whether it's deployed in hospitals, rural clinics, or community health centers, we empower healthcare systems to catch cancer early—when interventions have the greatest impact.